These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34431506)

  • 21. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
    Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
    Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
    Vithani K; Jannin V; Pouton CW; Boyd BJ
    Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of Artefenomel (OZ439) with Milk during Digestion: Insights into Digestion-Driven Solubilization and Polymorphic Transformations.
    Salim M; Khan J; Ramirez G; Clulow AJ; Hawley A; Ramachandruni H; Boyd BJ
    Mol Pharm; 2018 Aug; 15(8):3535-3544. PubMed ID: 29932660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
    Pouton CW
    Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S93-8. PubMed ID: 11033431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug solubility in fatty acids as a formulation design approach for lipid-based formulations: a technical note.
    Lee YC; Dalton C; Regler B; Harris D
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1551-1556. PubMed ID: 29873584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of digestion is essential to the understanding of milk as a drug delivery system for poorly water soluble drugs.
    Boyd BJ; Salim M; Clulow AJ; Ramirez G; Pham AC; Hawley A
    J Control Release; 2018 Dec; 292():13-17. PubMed ID: 30359667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Operando Analysis of Milk-Based Oral Formulations during Digestion Using Synchrotron Small-Angle X-ray Scattering Coupled to Low-Frequency Raman Spectroscopy.
    Be Rziņš KR; Meiland P; Aljabbari A; Boyd BJ
    Anal Chem; 2024 Jan; 96(2):887-894. PubMed ID: 38175633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addition of Cationic Surfactants to Lipid-Based Formulations of Poorly Water-Soluble Acidic Drugs Alters the Phase Distribution and the Solid-State Form of the Precipitate Upon In Vitro Lipolysis.
    Khan J; Rades T; Boyd BJ
    J Pharm Sci; 2018 Sep; 107(9):2420-2427. PubMed ID: 29859958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.
    Williams HD; Sassene P; Kleberg K; Calderone M; Igonin A; Jule E; Vertommen J; Blundell R; Benameur H; Müllertz A; Pouton CW; Porter CJ;
    Pharm Res; 2013 Dec; 30(12):3059-76. PubMed ID: 23661145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
    Feeney OM; Crum MF; McEvoy CL; Trevaskis NL; Williams HD; Pouton CW; Charman WN; Bergström CAS; Porter CJH
    Adv Drug Deliv Rev; 2016 Jun; 101():167-194. PubMed ID: 27089810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H; Holm R; Müllertz A
    Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
    Pouton CW
    Eur J Pharm Sci; 2006 Nov; 29(3-4):278-87. PubMed ID: 16815001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical In Vitro Characterization Methods of Lipid-Based Formulations for Oral Delivery: a Comprehensive Review.
    Swarnakar NK; Venkatesan N; Betageri G
    AAPS PharmSciTech; 2018 Dec; 20(1):16. PubMed ID: 30569266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies.
    Sahbaz Y; Nguyen TH; Ford L; McEvoy CL; Williams HD; Scammells PJ; Porter CJH
    Mol Pharm; 2017 Nov; 14(11):3669-3683. PubMed ID: 28954512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
    Carrière F
    Biochimie; 2016 Jun; 125():297-305. PubMed ID: 26607242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species.
    Chen XQ; Ziemba T; Huang C; Chang M; Xu C; Qiao JX; Wang TC; Finlay HJ; Salvati ME; Adam LP; Gudmundsson O; Hageman MJ
    J Pharm Sci; 2018 May; 107(5):1352-1360. PubMed ID: 29317226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.